{"meta":{"query_hash":"1617994b7276","filters":{"venue":"Journal of Lung Cancer"},"cohort_total":1,"direct_labels_cover":0,"predictions_cover":1,"exported":1,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/1617994b7276","api":"https://metacan.xera.ac/api/v1/cohort?venue=Journal+of+Lung+Cancer"},"results":[{"id":"W2114292376","doi":"10.6058/jlc.2009.8.2.61","title":"Comparison of Gefitinib versus Docetaxel in Patients with Pre-Treated Non-Small Cell Lung Cancer (NSCLC)","year":2009,"lang":"en","type":"article","venue":"Journal of Lung Cancer","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"","keywords":"Gefitinib; Docetaxel; Medicine; Oncology; Lung cancer; Internal medicine; Epidermal growth factor receptor; Population; Clinical trial; Cancer","score_opus":0.013719161576767482,"score_gpt":0.35969464480183744,"score_spread":0.34597548322506994,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114292376","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93210673,0.06392658,0.00018796668,0.0006399732,0.000727012,0.00034494573,0.00047375748,0.000026842978,0.0015662545],"genre_scores_gemma":[0.98857516,0.009677426,0.0001682399,0.0002642954,0.00025334634,0.00011415491,0.00033798252,0.000005243094,0.00060412055],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9990464,0.00052511407,0.00014124837,0.000104075545,0.00008404392,0.000099116376],"domain_scores_gemma":[0.9988888,0.0004779089,0.00028492184,0.000047110327,0.00007062291,0.00023059748],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014334366,0.0007455621,0.0034027274,0.00038899467,0.00024239435,0.0007831604,0.0004445653,0.00095239957,0.0019683337],"category_scores_gemma":[0.002579186,0.00034033266,0.003111837,0.00050598895,0.000374244,0.00075608684,0.00019234026,0.0017095763,0.0003076894],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9345322,0.002202737,0.0056648464,0.0017526504,0.0057442784,0.00013723441,0.00007833338,0.0005691676,0.0010722134,0.000116305055,0.0009308953,0.04719922],"study_design_scores_gemma":[0.5748567,0.34130794,0.059685417,0.0004270334,0.01525171,0.00059109397,0.00015893187,0.0013362949,0.0013718049,0.00040314335,0.0045216684,0.00008827073],"about_ca_topic_score_codex":0.0014720598,"about_ca_topic_score_gemma":0.0052235518,"teacher_disagreement_score":0.0034027274,"about_ca_system_score_codex":0.0012215466,"about_ca_system_score_gemma":0.000923401,"threshold_uncertainty_score":0.008863032},"labels":[],"label_agreement":null}]}